Search research articles
Contact Us
Filters
Showing results (11-20 of 162) with videos related to
Page
of 17
Sort By:
Mini Reviews in Medicinal Chemistry
|
July 19, 2011
Chelating agents and their use in radiopharmaceutical sciences
B Wängler, R Schirrmacher, P Bartenstein, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1990
[Immunoscintigraphy of the hematopoietic bone marrow in osteomyelofibrosis]
P Bartenstein, B Kirchner, K Scheidhauer, et al.
European Journal of Gynaecological Oncology
|
June 27, 2018
Metastatic mammary carcinoma despite histologically negative sentinel lymph nodes: are there any indicators for estimating recurrence and metastasis rates?
M Weiss, S Siegert, P Bartenstein, et al.
Brain : a Journal of Neurology
|
October 8, 1998
Reciprocal inhibitory visual-vestibular interaction. Visual motion stimulation deactivates the parieto-insular vestibular cortex
T Brandt, P Bartenstein, A Janek, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1992
[Cortical dysplasia as an epileptogenic focus: reduced binding of 123I-iomezanil with barely perceptible 99mTc-HMPAO SPECT]
P Bartenstein, C Lehmenkühler, J Sciuk, et al.
Current Medicinal Chemistry
|
February 17, 2010
Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging
C Wängler, R Schirrmacher, P Bartenstein, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|
January 1, 1988
[Improved scintigraphic imaging using cell separator-enriched. indium-111-oxinate marked granulocytes]
U Taborski, P Bartenstein, N Müller, et al.
Nuklearmedizin. Nuclear Medicine
|
March 22, 2000
[Combination systems for SPECT, coincidence, PET and CT. Technical spectrum, operating assumptions and possible areas of application]
U Büll, P Bartenstein, C M Kirsch, et al.
The American Journal of Psychiatry
|
September 5, 2001
Normal PET after long-term ECT
I Anghelescu, C J Klawe, P Bartenstein, et al.
Nuklearmedizin. Nuclear Medicine
|
May 7, 2004
Primary hyperoxaluria type 1: appearance in FDG PET, bone- and bone marrow scintigraphy
C T Kadalie, O Schreiner, H U Kauczor, et al.
Page
of 17
Search research articles
Search
Showing results (11-20 of 162) with videos related to
Sort By:
Page
of 17
Mini Reviews in Medicinal Chemistry
|
July 19, 2011
Chelating agents and their use in radiopharmaceutical sciences
B Wängler, R Schirrmacher, P Bartenstein, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1990
[Immunoscintigraphy of the hematopoietic bone marrow in osteomyelofibrosis]
P Bartenstein, B Kirchner, K Scheidhauer, et al.
European Journal of Gynaecological Oncology
|
June 27, 2018
Metastatic mammary carcinoma despite histologically negative sentinel lymph nodes: are there any indicators for estimating recurrence and metastasis rates?
M Weiss, S Siegert, P Bartenstein, et al.
Brain : a Journal of Neurology
|
October 8, 1998
Reciprocal inhibitory visual-vestibular interaction. Visual motion stimulation deactivates the parieto-insular vestibular cortex
T Brandt, P Bartenstein, A Janek, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1992
[Cortical dysplasia as an epileptogenic focus: reduced binding of 123I-iomezanil with barely perceptible 99mTc-HMPAO SPECT]
P Bartenstein, C Lehmenkühler, J Sciuk, et al.
Current Medicinal Chemistry
|
February 17, 2010
Click-chemistry reactions in radiopharmaceutical chemistry: fast & easy introduction of radiolabels into biomolecules for in vivo imaging
C Wängler, R Schirrmacher, P Bartenstein, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|
January 1, 1988
[Improved scintigraphic imaging using cell separator-enriched. indium-111-oxinate marked granulocytes]
U Taborski, P Bartenstein, N Müller, et al.
Nuklearmedizin. Nuclear Medicine
|
March 22, 2000
[Combination systems for SPECT, coincidence, PET and CT. Technical spectrum, operating assumptions and possible areas of application]
U Büll, P Bartenstein, C M Kirsch, et al.
The American Journal of Psychiatry
|
September 5, 2001
Normal PET after long-term ECT
I Anghelescu, C J Klawe, P Bartenstein, et al.
Nuklearmedizin. Nuclear Medicine
|
May 7, 2004
Primary hyperoxaluria type 1: appearance in FDG PET, bone- and bone marrow scintigraphy
C T Kadalie, O Schreiner, H U Kauczor, et al.
Page
of 17